Statin Therapy for High LDL and Low HDL

Introduction to Statin Selection

• The American College of Cardiology recommends initiating high-intensity statin therapy with either atorvastatin 40-80 mg or rosuvastatin 20-40 mg for patients with high LDL and low HDL, with rosuvastatin demonstrating superior efficacy in achieving ≥50% LDL-C reduction and improving the LDL-C/HDL-C ratio 1, 2

Statin Intensity Selection

• High-intensity statin therapy is the cornerstone of treatment for patients with dyslipidemia characterized by elevated LDL and low HDL, as this combination significantly increases cardiovascular risk 1, 2
• High-intensity statins are defined as those achieving ≥50% LDL-C reduction and include atorvastatin 40-80 mg and rosuvastatin 20-40 mg 1, 2

Treatment Algorithm

• Very high-risk patients should start high-intensity statin immediately 1
• High-risk patients should start high-intensity statin 1
• Diabetes patients age ≥40 years should start moderate-to-high intensity statin 3

Special Considerations

• All patients with diabetes age ≥40 years should receive statin therapy regardless of baseline LDL-C 3
• High-intensity statin is recommended if 10-year ASCVD risk >20% or established ASCVD 3
• High-intensity statins increase new-onset diabetes risk by 36% (RR 1.36, 95% CI 1.25-1.48), representing 1.27% absolute annual excess 5

Monitoring and Follow-up

• Recheck lipid panel 4-6 weeks after initiation or dose change 1, 8
• Once at goal, monitor every 6-12 months 8
• Monitor for myopathy symptoms, particularly with higher doses 1, 2